Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
LYEL | Lyell Immunopharma, Inc. | Chief Financial Officer | $271K | +$93.5K | +52.6% | Aug 20, 2025 |
TSVT | 2seventy bio, Inc. | Director | $47.4K | May 13, 2025 | ||
CHRS | Coherus BioSciences, Inc. | Director | Jun 12, 2025 | |||
NVAX | NOVAVAX INC | Director | Apr 25, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|